Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine for biliary-cardiac reflex and postoperative pain in laparoscopic cholecystectomy
ChiCTR2400079362Phase 4Recruiting
- Sponsor
- Xiangyang Central Hospital
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain, anxiety disorder, major depressive disorder (MDD) and 1 more (2 arms), sponsored by Xiangyang Central Hospital. Primary endpoints: biliary-cardiac reflex and VAS pain score. Started Jan 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painanxiety disordermajor depressive disorder (MDD)post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2400079362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079362.